Show simple item record

dc.contributor.authorAntozzi, C.
dc.contributor.authorEvoli, A.
dc.contributor.authorBrenner, T.
dc.contributor.authorVaknin, A.
dc.contributor.authorBerrih-Aknin, S.
dc.contributor.authorBehin, A.
dc.contributor.authorSharshar, T.
dc.contributor.authorDe Baets, M.
dc.contributor.authorLosen, M.
dc.contributor.authorMartinez-Martinez, P.
dc.contributor.authorKleopa, K. A.
dc.contributor.authorZamba-Papanicolaou, E.
dc.contributor.authorKyriakides, T.
dc.contributor.authorKostera-Pruszczyk, A.
dc.contributor.authorSzczudlik, P.
dc.contributor.authorSzyluk, B.
dc.contributor.authorLavrnic, D.
dc.contributor.authorBasta, I.
dc.contributor.authorPeric, S.
dc.contributor.authorTallaksen, C.
dc.contributor.authorManiaol, A.
dc.contributor.authorPons, C. Casasnovas
dc.contributor.authorPitha, J.
dc.contributor.authorJakubikova, M.
dc.contributor.authorHanisch, F.
dc.contributor.authorTzartos, S. J.
dc.contributor.authorDeymeer, F.
dc.contributor.authorSaruhan-Direskeneli, G.
dc.contributor.authorDurmus, Hacer
dc.contributor.authorTsonis, A. I.
dc.contributor.authorZisimopoulou, P.
dc.contributor.authorLazaridis, K.
dc.contributor.authorTzartos, J.
dc.contributor.authorMatsigkou, E.
dc.contributor.authorZouvelou, V.
dc.contributor.authorMantegazza, R.
dc.contributor.authorAndreetta, F.
dc.date.accessioned2021-03-04T13:25:03Z
dc.date.available2021-03-04T13:25:03Z
dc.identifier.citationTsonis A. I. , Zisimopoulou P., Lazaridis K., Tzartos J., Matsigkou E., Zouvelou V., Mantegazza R., Antozzi C., Andreetta F., Evoli A., et al., "MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.", Journal of neuroimmunology, cilt.284, ss.10-7, 2015
dc.identifier.issn0165-5728
dc.identifier.othervv_1032021
dc.identifier.otherav_7c49ff84-ae79-4fd3-b5b6-cadf0c0060ae
dc.identifier.urihttp://hdl.handle.net/20.500.12627/85015
dc.identifier.urihttps://doi.org/10.1016/j.jneuroim.2015.04.015
dc.description.abstractSeronegative myasthenia gravis (MG) presents a serious gap in MG diagnosis and understanding. We applied a cell based assay (CBA) for the detection of muscle specific kinase (MuSK) antibodies undetectable by radioimmunoassay. We tested 633 triple-seronegative MG patients' sera from 13 countries, detecting 13% as positive. MuSK antibodies were found, at significantly lower frequencies, in 1.9% of healthy controls and 5.1% of other neuroimmune disease patients, including multiple sclerosis and neuromyelitis optica. The clinical data of the newly diagnosed MuSK-MG patients are presented. 27% of ocular seronegative patients were MuSK antibody positive. Moreover, 23% had thymic hyperplasia suggesting that thymic abnormalities are more common than believed. (C) 2015 Elsevier B.V. All rights reserved.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri
dc.titleMuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.
dc.typeMakale
dc.relation.journalJournal of neuroimmunology
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume284
dc.identifier.startpage10
dc.identifier.endpage7
dc.contributor.firstauthorID223413


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record